• What We Do
  • Who We Are
  • Simulations
  • Presentations & Research
  • Contact Us
  • White Paper
  • Disclaimer
  • Industry Sector
  • Global Region
  • Major Funds - Holding
  • Tutorial
  • Best Risk Adjusted
  • Worst Risk Adjusted
  • Best Expected
  • Worst Expected
  • Sector Ranking
  • Dividend
  • REIT's
  • Leverage Risk
  • Convertible Bonds
  • Investment Grade
  • High Yield
  • ADR
  • Small Caps
Rational Investing
  • About Usarrow_drop_down
  • Coveragearrow_drop_down
  • Returnsarrow_drop_down
  • Productarrow_drop_down
  • ETF's and Futures


Drugs - Generic

       Total Market Capitalization of All Firms $42,281 mm             
       Average Market Capitalization $7,047 mm       
       Average Market to Model Ratio Weighted by Log of Market Cap 1.2       
       Standard Deviation of MM Ratio 0.3       
       Average Beta 1.0       
       Average EV To Revenue 2.1       
       Average EV To EBITDAM 17.9       
       Average Price To Free Cash Flow 13.4       

TickerCompany NameMarket To ModelMarket Cap ($ mm)EV to RevenuePrice To FCFEV/EBITDAM% GrowthBetaAs Of
ANIPANI Pharmaceuticals Inc1.745223.416.418.141.3Sep 19
PBHPrestige Brands Holdings Inc.1.472,8834.014.713.0160.7Sep 21
PRGOPerrigo Co.1.384,7911.715.012.4-41.0Sep 21
RDYDr Reddy Laboratories Ltd1.0210,3443.822.415.3100.3Jun 21
MYLMylan N.V.0.8714,746-2.18.740-3021.5Dec 20
TEVATeva Pharmaceutical Industries0.798,9962.13.48.401.4Sep 21
Standard Value | About us | Contact us     Copyright © 2003-2021 Rational Investing LLC ® | All Rights Reserved